Behind the Science: Behind Clinical Perspectives on Antimicrobial Stewardship

During the COVID-19 pandemic, the emphasis and urgency was placed on treating the novel coronavirus. As a result, many important initiatives such as antimicrobial resistance (AMR) were put on hold. For example, studies have shown more antibiotics were prescribed during the first year of the pandemic. As the pandemic now begins to evolve into a new phase, clinicians can once again turn back again to the AMR issue. Clinicians offer insights into what medical community is doing right in this area where the challenges remain.